Summary by Moomoo AI
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 10, 2024 DISCLOSING DETAILS OF THE COMPANY'S SHARE REPURCHASE. According to the report, between April 2 and April 10, 2024, the company repurchased a total of 7,150,000 shares of ordinary shares through the United Stock Exchange of Hong Kong Limited (HKEx), representing 0.2916% of the issued shares. Of these, 1,030,000 shares were repurchased on the single day of April 10 at a price of HKD 7.36 to HKD 7.56, with a total repurchase amount of HKD 7,670,420 on the same day. The share repurchase was conducted pursuant to an official mandate from the Company's Board of Directors and the relevant listing rules and has complied with all relevant legal and regulatory requirements.